Chronic left ventricular failure: the role of imaging in diagnosis and planning of conventional and novel therapies

被引:1
|
作者
Hoey, E. T. D. [1 ]
Gopalan, D. [1 ]
Agrawal, S. K. B. [1 ]
Screaton, N. J. [1 ]
机构
[1] Papworth Hosp, Dept Radiol, Cambridge CB3 8RE, England
关键词
CORONARY-ARTERY-DISEASE; AORTIC-VALVE AREA; CARDIAC RESYNCHRONIZATION THERAPY; EMISSION-COMPUTED-TOMOGRAPHY; CHRONIC HEART-FAILURE; MYOCARDIAL VIABILITY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; INTERNATIONAL-SOCIETY; LUNG-TRANSPLANTATION; DIASTOLIC FUNCTION;
D O I
10.1016/j.crad.2008.10.009
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Heart failure is the leading cause of hospitalisation in the UK, and its prevalence is expected to increase further in the future due partly to an aging population. Although pharmacological agents remain the mainstay of therapy, an increasing number of surgical and novel minimally invasive interventions have been developed for the treatment of both acute and chronic heart failure. Imaging is essential for diagnosis, guiding therapeutic options, and monitoring therapy and its complications. As a result, radiologists should be familiar with the pathogenesis, treatment options, and imaging-related issues pertaining to the management of these patients. (C) 2008 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:238 / 249
页数:12
相关论文
共 50 条
  • [41] Left Ventricular Flow Analysis Novel Imaging Biomarkers and Predictors of Exercise Capacity in Heart Failure
    Stoll, Victoria M.
    Hess, Aaron T.
    Rodgers, Christopher T.
    Bissell, Malenka M.
    Dyverfeldt, Petter
    Ebbers, Tino
    Myerson, Saul G.
    Carlhaell, Carl-Johan
    Neubauer, Stefan
    CIRCULATION-CARDIOVASCULAR IMAGING, 2019, 12 (05)
  • [42] The beginning of the end for conventional RECIST - novel therapies require novel imaging approaches
    Gerwing, Mirjam
    Herrmann, Ken
    Helfen, Anne
    Schliemann, Christoph
    Berdel, Wolfgang E.
    Eisenblaetter, Michel
    Wildgruber, Moritz
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (07) : 442 - 458
  • [43] The beginning of the end for conventional RECIST — novel therapies require novel imaging approaches
    Mirjam Gerwing
    Ken Herrmann
    Anne Helfen
    Christoph Schliemann
    Wolfgang E. Berdel
    Michel Eisenblätter
    Moritz Wildgruber
    Nature Reviews Clinical Oncology, 2019, 16 : 442 - 458
  • [44] Prognostic role of the left ventricular global function index companion in patients with chronic heart failure
    Larina, Vera N.
    Lunev, Viktor I.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 117 : 134 - 136
  • [45] The role of exercise hemodynamics in assessing patients with chronic heart failure and left ventricular assist devices
    Koshy, Aaron
    Green, Thomas
    Toms, Anet
    Cassidy, Sophie
    Schueler, Stephan
    Jakovljevic, Djordje
    MacGowan, Guy A.
    EXPERT REVIEW OF MEDICAL DEVICES, 2019, 16 (10) : 891 - 898
  • [46] The Role of Multimodality Imaging in Right Ventricular Failure
    Wang, Tom Kai Ming
    Jellis, Christine
    CARDIOLOGY CLINICS, 2020, 38 (02) : 203 - +
  • [47] Evaluation of Left Ventricular Function by Conventional Echocardiography and Tissue Doppler Imaging in Patients with Acute and Chronic Mitral Regurgitation
    Ramazan, Kargin
    Mustafa, Bulut
    Yunus, Emiroglu
    Halil, Mutlu
    Selcuk, Pala
    Mustafa, Akcakoyun
    Cihan, Cevik
    Moe, Aung Soe
    Nihal, Oezdemir
    JOURNAL OF MEDICAL ULTRASOUND, 2011, 19 (04) : 122 - 127
  • [48] Unique role of cardiovascularmagnetic resonance imaging parametric mapping in the diagnosis of arrhythmogenic left ventricular cardiomyopathy
    Dowd, Rory
    Dhanjal, Tarvinder
    Schmucki, Michelle
    Kanagala, Prathap
    Khan, Jamal Nasir
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2021, 22 (07) : E96 - E96
  • [49] Pulmonary hypertension: diagnosis, imaging techniques, and novel therapies
    Goldberg, Alan B.
    Mazur, Wojciech
    Kalra, Dinesh K.
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2017, 7 (04) : 405 - 417
  • [50] The Role of β-Blockers in Left Ventricular Dysfunction and Heart Failure
    Åke Hjalmarson
    Maria Kneider
    Finn Waagstein
    Drugs, 1997, 54 : 501 - 510